Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-Current Deffered Revenue (2019 - 2020)

Historic Non-Current Deffered Revenue for Pliant Therapeutics (PLRX) over the last 2 years, with Q4 2020 value amounting to $581000.0.

  • Pliant Therapeutics' Non-Current Deffered Revenue rose 2685.59% to $581000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $581000.0, marking a year-over-year increase of 2685.59%. This contributed to the annual value of $581000.0 for FY2020, which is 2685.59% up from last year.
  • Per Pliant Therapeutics' latest filing, its Non-Current Deffered Revenue stood at $581000.0 for Q4 2020, which was up 2685.59% from $565000.0 recorded in Q3 2020.
  • In the past 5 years, Pliant Therapeutics' Non-Current Deffered Revenue ranged from a high of $581000.0 in Q4 2020 and a low of $458000.0 during Q4 2019